搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Ornithine carbamoyltransferase, catabolic (arcB) CSB-YP352039MLK
CSB-EP352039MLK
CSB-BP352039MLK
CSB-MP352039MLK
CSB-EP352039MLK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alginate biosynthesis protein AlgJ (algJ) CSB-YP352040FFT
CSB-EP352040FFT
CSB-BP352040FFT
CSB-MP352040FFT
CSB-EP352040FFT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rhodopirellula baltica UPF0272 protein RB10177 (RB10177) CSB-YP352041RDR
CSB-EP352041RDR
CSB-BP352041RDR
CSB-MP352041RDR
CSB-EP352041RDR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter hepaticus 3-oxoacyl-[acyl-carrier-protein] synthase 3 (fabH) CSB-YP352042HCO
CSB-EP352042HCO
CSB-BP352042HCO
CSB-MP352042HCO
CSB-EP352042HCO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Helicobacter hepaticus Ribosome maturation factor RimP (rimP) CSB-YP352043HCO
CSB-EP352043HCO
CSB-BP352043HCO
CSB-MP352043HCO
CSB-EP352043HCO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Ribosomal large subunit pseudouridine synthase C (rluC) CSB-YP352044HSY
CSB-EP352044HSY
CSB-BP352044HSY
CSB-MP352044HSY
CSB-EP352044HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Fumarate reductase subunit D (frdD), partial CSB-YP352045HSY1
CSB-EP352045HSY1
CSB-BP352045HSY1
CSB-MP352045HSY1
CSB-EP352045HSY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactococcus lactis subsp. lactis Lactococcin-G-processing and transport ATP-binding protein LagD (lagD), partial CSB-YP352046LNI1
CSB-EP352046LNI1
CSB-BP352046LNI1
CSB-MP352046LNI1
CSB-EP352046LNI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Marichromatium purpuratum High-potential iron-sulfur protein (hip) CSB-YP352047MCD
CSB-EP352047MCD
CSB-BP352047MCD
CSB-MP352047MCD
CSB-EP352047MCD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Heterometrus spinifer Potassium channel toxin alpha-KTx 6.3 CSB-YP352048HGS
CSB-EP352048HGS
CSB-BP352048HGS
CSB-MP352048HGS
CSB-EP352048HGS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella suis biovar 1 tRNA pseudouridine synthase B (truB) CSB-YP352049BMQ
CSB-EP352049BMQ
CSB-BP352049BMQ
CSB-MP352049BMQ
CSB-EP352049BMQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Prochlorococcus marinus subsp. pastoris tRNA pseudouridine synthase B (truB) CSB-YP352050EYQ
CSB-EP352050EYQ
CSB-BP352050EYQ
CSB-MP352050EYQ
CSB-EP352050EYQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Buthus sindicus Chlorotoxin-like peptide Bs 14 CSB-YP352051BOD
CSB-EP352051BOD
CSB-BP352051BOD
CSB-MP352051BOD
CSB-EP352051BOD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Centruroides limpidus limpidus Toxin Cll2b CSB-YP352052CGA
CSB-EP352052CGA
CSB-BP352052CGA
CSB-MP352052CGA
CSB-EP352052CGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spirogyra maxima Photosystem II reaction center protein T (psbT), partial CSB-YP352053FKM
CSB-EP352053FKM
CSB-BP352053FKM
CSB-MP352053FKM
CSB-EP352053FKM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi Ubiquinone/menaquinone biosynthesis methyltransferase ubiE (ubiE) CSB-YP352054HSY
CSB-EP352054HSY
CSB-BP352054HSY
CSB-MP352054HSY
CSB-EP352054HSY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus ducreyi UPF0283 membrane protein HD_1769 (HD_1769), partial CSB-YP352055HSY1
CSB-EP352055HSY1
CSB-BP352055HSY1
CSB-MP352055HSY1
CSB-EP352055HSY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mesobuthus martensii Potassium channel toxin gamma-KTx 2.2 CSB-YP352056MRE
CSB-EP352056MRE
CSB-BP352056MRE
CSB-MP352056MRE
CSB-EP352056MRE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Leiurus quinquestriatus hebraeus Potassium channel toxin alpha-KTx 1.13 CSB-YP352057LDS
CSB-EP352057LDS
CSB-BP352057LDS
CSB-MP352057LDS
CSB-EP352057LDS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Glutamate 5-kinase (proB) CSB-YP352058MVH
CSB-EP352058MVH
CSB-BP352058MVH
CSB-MP352058MVH
CSB-EP352058MVH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>